Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,481 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Completed

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

NCT01988506

Conditions
Ankylosing Spondylitis, Ankylosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +90 more
Locations
  • Henri Mondor - Médecine Interne Créteil, France
  • Médecine interne - Hôpital Saint-Antoine Paris, France
  • Service de médecine vasculaire - HEGP Paris, France
  • Service d' Hépato Gastro Entérologie - Hôpital SAINT-ANTOINE Paris, Île-de-France Region, France
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors

NCT02622321

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Santa Monica Oncology Center Santa Monica, California, United States
  • University of Colorado Denver, Children's Hospital Aurora, Colorado, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 44 locations
View Trial Details
Completed

French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia

NCT01192347

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • GH Pitie Salpetriere Paris, Cedex 13, France
  • CH DU Pays D Aix Aix-en-Provence, Cedex 1, France
  • Hopital Dupuytren Limoges, Cedex 1, France
  • Hopital Emile Muller Mulhouse, Cedex 1, France
View all 46 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors

NCT03191799

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Royal Prince Alfred Hospital; Haematology Camperdown, New South Wales, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Fiona Stanley Hospital Murdoch, Western Australia, Australia
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 72 locations
View Trial Details
Completed

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

NCT01214915

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Juntendo University Hospital Hongo 3-1-3, Bunkyo-ku, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Kom Honkomagome 3-18-22, Bunkyo-ku, Japan
  • Nippon Medical School Hospital Sendagi 1-1-5, Bunkyo-ku, Japan
View all 19 locations
View Trial Details
Completed

Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

NCT01467661

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Kom Honkomagome 3-18-22, Bunkyo-ku, Japan
  • Nippon Medical School Hospital Sendagi 1-1-5, Bunkyo-ku, Japan
  • Chiba University Hospital Chuo-ku Inohana 1-8-1, Chiba-shi, Japan
View all 16 locations
View Trial Details
Completed

Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

NCT00567502

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +6 more
Locations
  • Clinic of Haematology Limassol, Cyprus
  • Rigshospitalet Copenhagen, Denmark
  • SUS-Esbjerg Maematologisk afdelning Esbjerg, Denmark
  • Herlev Hospital Herlev, Denmark
View all 164 locations
View Trial Details

Related conditions